tiprankstipranks
Advertisement
Advertisement

GALT Stock Latest News

Galectin Therapeutics (GALT) (GALT) Q4 Earnings Cheat Sheet
Pre-EarningsGalectin Therapeutics (GALT) (GALT) Q4 Earnings Cheat Sheet
3d ago
GALT
Galectin Therapeutics Adds Neurosurgeon Henry Brem to Board
PremiumCompany Announcements
Galectin Therapeutics Adds Neurosurgeon Henry Brem to Board
10d ago
8K
GALT
Galectin Therapeutics appoints Henry Brem to board of directors
PremiumThe Fly
Galectin Therapeutics appoints Henry Brem to board of directors
10d ago
GALT
Compelling Risk‑Reward in Galectin Therapeutics: Belapectin’s Differentiated Profile and Biomarker Data Support Buy Rating
PremiumRatings
Compelling Risk‑Reward in Galectin Therapeutics: Belapectin’s Differentiated Profile and Biomarker Data Support Buy Rating
16d ago
GALT
Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
PremiumCompany Announcements
Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
1M ago
GALT
Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
PremiumCompany AnnouncementsGalectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT
1M ago
GALT
Galectin Therapeutics Approves Retention Bonuses for Key Executives
Premium
Company Announcements
Galectin Therapeutics Approves Retention Bonuses for Key Executives
2M ago
8K
GALT
Galectin Therapeutics announces board resignation of Marc Rubin
Premium
Company Announcements
Galectin Therapeutics announces board resignation of Marc Rubin
2M ago
8K
GALT
Galectin Advances Belapectin Program, Secures New Insider Financing
PremiumCompany Announcements
Galectin Advances Belapectin Program, Secures New Insider Financing
3M ago
8K
GALT
Galectin Therapeutics provides regulatory update following FDA written response
PremiumThe Fly
Galectin Therapeutics provides regulatory update following FDA written response
3M ago
GALT
Galectin Therapeutics price target raised to $11 from $6 at H.C. Wainwright
PremiumThe Fly
Galectin Therapeutics price target raised to $11 from $6 at H.C. Wainwright
3M ago
GALT
Galectin Therapeutics Holds 2025 Annual Stockholders Meeting
PremiumCompany Announcements
Galectin Therapeutics Holds 2025 Annual Stockholders Meeting
4M ago
8K
GALT
Galectin Therapeutics Reveals Promising NAVIGATE Trial Results
PremiumCompany AnnouncementsGalectin Therapeutics Reveals Promising NAVIGATE Trial Results
4M ago
8K
GALT
Galectin Therapeutics Reports Q3 2025 Financials
Premium
Company Announcements
Galectin Therapeutics Reports Q3 2025 Financials
4M ago
GALT
Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment
Premium
Ratings
Promising Phase 2 Data Boosts Confidence in Galectin Therapeutics’ Belapectin for Fibrotic Disease Treatment
4M ago
GALT
Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year
PremiumThe Fly
Galectin Therapeutics reports Q4 EPS (13c) vs (18c) last year
4M ago
GALT
Galectin Therapeutics presents NAVIGATE trial results at AASLD
PremiumThe Fly
Galectin Therapeutics presents NAVIGATE trial results at AASLD
5M ago
GALT
Galectin Therapeutics Presents Promising NAVIGATE Trial Results
PremiumCompany Announcements
Galectin Therapeutics Presents Promising NAVIGATE Trial Results
5M ago
8K
GALT
Galectin Therapeutics Highlights Promising Belapectin Results
PremiumCompany Announcements
Galectin Therapeutics Highlights Promising Belapectin Results
7M ago
8K
GALT
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
7M ago
ING
AMPY
Galectin Therapeutics Reports Reduced Losses in Q2 2025
Premium
Company Announcements
Galectin Therapeutics Reports Reduced Losses in Q2 2025
7M ago
GALT
Optimistic Buy Rating for Galectin Therapeutics Driven by Belapectin’s Potential in Treating Liver Cirrhosis and Strategic Focus
Premium
Ratings
Optimistic Buy Rating for Galectin Therapeutics Driven by Belapectin’s Potential in Treating Liver Cirrhosis and Strategic Focus
7M ago
GALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >